All kidding aside, CHEK is an excellent buy this week with expected news on clinical trials coming into next week. I see this stock sending it to $10.00 a share on good news. Once CHEK is fully in orbit we will begin the journey to full retracement and beyond!
**None of this is professional advice and I wish you all the best! Trade safe.